Unipolare Depression Langfassung - Versorgungsleitlinien.de
Unipolare Depression Langfassung - Versorgungsleitlinien.de
Unipolare Depression Langfassung - Versorgungsleitlinien.de
Erfolgreiche ePaper selbst erstellen
Machen Sie aus Ihren PDF Publikationen ein blätterbares Flipbook mit unserer einzigartigen Google optimierten e-Paper Software.
550. Kallner G, Lin<strong>de</strong>lius R, Petterson U, Stockman O, Tham A. Mortality in 497 patients with<br />
affective disor<strong>de</strong>rs attending a lithium clinic or after having left it. Pharmacopsychiatry<br />
2000;33(1):8-13.<br />
551. Coppen A. Lithium in unipolar <strong>de</strong>pression and the prevention of suici<strong>de</strong>. J Clin Psychiatry<br />
2000;61 Suppl 9:52-6.<br />
552. Berghofer A, Adli M, Baethge C, Deutsche Gesellschaft für Bipolare Störungen.<br />
Phasenprophylaxe. Hamburg: ConferencePoint Verl.; 2003.<br />
553. Schou M. Suicidal behavior and prophylactic lithium treatment of major mood disor<strong>de</strong>rs: a<br />
review of reviews. Suici<strong>de</strong> Life Threat Behav 2000;30(3):289-93.<br />
554. Müller-Oerlinghausen B, Wolf T, Ahrens B, Schou M, Grof E, Grof P, Lenz G, Simhandl C,<br />
Thau K, Wolf R. Mortality during initial and during later lithium treatment. A collaborative study<br />
by the International Group for the Study of Lithium-treated Patients. Acta Psychiatr Scand<br />
1994;90(4):295-7.<br />
555. Thies-Flechtner K, Müller-Oerlinghausen B, Seibert W, Walther A, Greil W. Effect of<br />
prophylactic treatment on suici<strong>de</strong> risk in patients with major affective disor<strong>de</strong>rs. Data from a<br />
randomized prospective trial. Pharmacopsychiatry 1996;29(3):103-7.<br />
556. Goodwin FK. Anticonvulsant therapy and suici<strong>de</strong> risk in affective disor<strong>de</strong>rs. J Clin Psychiatry<br />
1999;60 Suppl 2:89-93.<br />
557. Placidi GF, Lenzi A, Lazzerini F, Cassano GB, Akiskal HS. The comparative efficacy and<br />
safety of carbamazepine versus lithium: a randomized, double-blind 3-year trial in 83 patients.<br />
J Clin Psychiatry 1986;47(10):490-4.<br />
558. Simhandl C, Denk E, Thau K. The comparative efficacy of carbamazepine low and high serum<br />
level and lithium carbonate in the prophylaxis of affective disor<strong>de</strong>rs. J Affect Disord<br />
1993;28(4):221-31.<br />
559. Dang T, Engel RR. Long-term drug treatment of bipolar and <strong>de</strong>pressive disor<strong>de</strong>rs: metaanalysis<br />
of controlled trials with lithium, carbamazepime and anti<strong>de</strong>pressive agents.<br />
Pharmacopsychiatry 1995;28:170.<br />
560. Calabrese JR, Bow<strong>de</strong>n CL, Sachs G, Yatham LN, Behnke K, Mehtonen OP, Montgomery P,<br />
Ascher J, Paska W, Earl N, Veaugh-Geiss J. A placebo-controlled 18-month trial of<br />
lamotrigine and lithium maintenance treatment in recently <strong>de</strong>pressed patients with bipolar I<br />
disor<strong>de</strong>r. J Clin Psychiatry 2003;64(9):1013-24.<br />
561. Alda M. The phenotypic spectra of bipolar disor<strong>de</strong>r. Eur Neuropsychopharmacol 2004;14<br />
Suppl 2:S94-S99.<br />
562. Cowen PJ. Pharmacological management of treatment resistant <strong>de</strong>pression. Adv Psychiatr<br />
Treat 1998;4:320-7.<br />
563. Thase ME, Rush AJ. Treatment-resistent <strong>de</strong>pression. In: Bloom FE, Kupfer DJ, editors.<br />
Psychopharmacology. The forth generation of progress. New York: Raven Pr.; 1995. p. 1081-<br />
97<br />
564. Bauer M, Berghöfer A, Adli M. Akute und therapieresistente <strong>Depression</strong>en.<br />
Pharmakotherapie-Psychotherapie-Innovationen. 2nd ed. Berlin: Springer; 2005.<br />
565. Kirchheiner J, Brosen K, Dahl ML, Gram LF, Kasper S, Roots I, Sjoqvist F, Spina E,<br />
Brockmoller J. CYP2D6 and CYP2C19 genotype-based dose recommendations for<br />
anti<strong>de</strong>pressants: a first step towards subpopulation-specific dosages. Acta Psychiatr Scand<br />
2001;104(3):173-92.<br />
566. Kirchheiner J, Nickchen K, Bauer M, Wong ML, Licinio J, Roots I, Brockmoller J.<br />
Pharmacogenetics of anti<strong>de</strong>pressants and antipsychotics: the contribution of allelic variations<br />
to the phenotype of drug response. Mol Psychiatry 2004;9(5):442-73.<br />
567. Baumann P, Hiemke C, Ulrich S, Eckermann G, Gaertner I, Gerlach M, Kuss HJ, Laux G,<br />
Müller-Oerlinghausen B, Rao ML, Rie<strong>de</strong>rer P, Zernig G. The AGNP-TDM expert group<br />
consensus gui<strong>de</strong>lines: therapeutic drug monitoring in psychiatry. Pharmacopsychiatry<br />
2004;37(6):243-65.<br />
© 2009 229